IMMUNE CHECKPOINT INHIBITORS (ICIS)
Clinical trials for IMMUNE CHECKPOINT INHIBITORS (ICIS) explained in plain language.
Never miss a new study
Get alerted when new IMMUNE CHECKPOINT INHIBITORS (ICIS) trials appear
Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITORS (ICIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can stem cell mist heal lungs damaged by cancer immunotherapy?
Disease control Not yet recruitingThis early-phase trial tests whether inhaling tiny particles from stem cells (exosomes) can help heal lung inflammation caused by immunotherapy drugs. The study involves 40 adults with cancer who have persistent lung problems despite standard steroid treatment. Participants will …
Matched conditions: IMMUNE CHECKPOINT INHIBITORS (ICIS)
Phase: PHASE1, PHASE2 • Sponsor: Zhou Chengzhi • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Cancer combo therapy under the microscope: real-world study launched
Knowledge-focused Not yet recruitingThis study will observe 200 cancer patients who are already receiving immunotherapy (immune checkpoint inhibitors) along with radiotherapy. Researchers want to see how long the cancer stays under control and how patients fare overall, in everyday clinical practice rather than a s…
Matched conditions: IMMUNE CHECKPOINT INHIBITORS (ICIS)
Sponsor: Sichuan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
New study aims to predict immunotherapy success in cancer patients
Knowledge-focused Not yet recruitingThis study will collect data from 500 cancer patients who are about to start immunotherapy. Researchers want to build a tool that can predict survival outcomes based on factors like combination treatments. The goal is to help doctors and patients make more informed decisions abou…
Matched conditions: IMMUNE CHECKPOINT INHIBITORS (ICIS)
Sponsor: Sichuan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC